Triapine
- Generic Name
- Triapine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C7H9N5S
- CAS Number
- 143621-35-6
- Unique Ingredient Identifier
- U4XIL4091C
- Background
Triapine has been used in trials studying the treatment of Leukemia, Lung Cancer, Kidney Cancer, Prostate Cancer, and Pancreatic Cancer, among others.
- Associated Conditions
- -
- Associated Therapies
- -
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
- Conditions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- Vion Pharmaceuticals
- Registration Number
- NCT00064051
- Locations
- ๐บ๐ธ
Indiana Oncology Hematology Consultants, Indianapolis, Indiana, United States
๐บ๐ธUniversity of Minnesota Cancer Center, Minneapolis, Minnesota, United States
๐บ๐ธUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
Combination Chemotherapy in Treating Patients With Advanced Cancer
- Conditions
- First Posted Date
- 2003-06-20
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- Vion Pharmaceuticals
- Registration Number
- NCT00024323
- Locations
- ๐บ๐ธ
Arizona Clinical Research Center, Tucson, Arizona, United States
๐บ๐ธYale Comprehensive Cancer Center, New Haven, Connecticut, United States
3-AP in Treating Patients With Advanced Prostate Cancer
- Conditions
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Vion Pharmaceuticals
- Registration Number
- NCT00054015
- Locations
- ๐บ๐ธ
UCSF Comprehensive Cancer Center, San Francisco, California, United States
๐บ๐ธH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.